| COMPANY |
Intellia Therapeutics, Inc. |
| COURT |
United States District Court for the District of Massachusetts |
| CASE NUMBER |
1:25-cv-10353 |
| JUDGE |
The Hon. Denise Jefferson Casper |
| CLASS PERIOD |
July 30, 2024 through January 8, 2025 |
| SECURITY TYPE |
Securities |
LEAD PLAINTIFF DEADLINE IS APRIL 14, 2025.
If you have suffered losses and would like to discuss your rights, please fill out this form or you may contact Jonathan Naji, Esq. at (484) 270-1453 or via e-mail at info@ktmc.com.
Case Background:
A class action lawsuit was filed on behalf of those who purchased or otherwise acquired Intellia Therapeutics, Inc. (“Intellia”) (NASDAQ: NTLA) securities between July 30, 2024, and January 8, 2025, inclusive (the “Class Period”).
The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, Defendants misrepresented and/or failed to disclose that: (1) the demand for viral-based editing was rapidly dwindling due to cost-effectiveness and more efficient development of non-viral delivery methods; (2) Intellia was not equipped to timely dose patients with NTLA-3001, maintain the drug’s research and development, or maintain its full staff in light of the existing scientific landscape surrounding viral-based editing drugs; and (3) as a result, Defendants’ statements about the company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
What is a Lead Plaintiff?
A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. Filling out the online form above or communicating with any counsel is not necessary to participate or share in any recovery achieved in this case. Any member of the purported class may move the court to serve as a lead plaintiff through counsel of his/her choice, or may choose to do nothing and remain an inactive class member.